In hospitals across the world, a quiet race against time plays out each day as thousands of patients wait for a new heart that may never come. Doctors, scientists and policymakers have spent years trying to figure out the fairest way to decide who gets this life-saving gift first. From advanced computer scoring systems to urgent care-based rankings, the hope has always been clear: find the one system that saves the most lives while staying fair. But new global insights suggest that this “perfect system” may not exist at all.

At the 46th Annual Meeting of the International Society for Heart and Lung Transplantation, experts examined how countries allocate donor hearts, a question that sits at the heart of modern transplant medicine. Every year, around 7,000 heart transplants occur globally, but the demand far exceeds the supply. In fact, nearly 10 to 15 per cent of patients on waiting lists die before a suitable heart becomes available.

“A shortage in donor hearts is the primary limiting factor to performing more heart transplants,” said Dr Guillaume Coutance, a cardiologist at Georges Pompidou European Hospital in Paris. His words cut through the technical debate with stark clarity. Even as the system becomes more sophisticated, the supply of hearts is limited.

Various countries have tried different approaches. Most rely on what doctors call a status-based system, where patients are grouped by how sick they are. Those on life-support machines like ECMO—a device that temporarily takes over the work of the heart and lungs—are often pushed to the top of the list. It sounds logical and urgent, but experts warn it may sometimes reflect how aggressively a patient is treated rather than how critically ill they truly are.

France, on the other hand, has taken a more data-driven path. In 2018, it introduced a score-based system that uses complex statistical models to rank patients. This model considers several factors, including the risk of dying within a year without a transplant, organ compatibility, and even travel time between donor and recipient hospitals. The aim is to create a more balanced, individualised decision for each patient.

On paper, the French system appears almost futuristic—like a finely tuned algorithm designed to remove human bias. It calculates risk using detailed medical indicators such as kidney and liver function, need for mechanical support, and markers of heart failure. Doctors hoped that such precision would improve survival rates and make the process more transparent.

Yet the reality has been unexpectedly sobering.

“No allocation system has proven clearly superior in terms of improving both pre- and post-transplant outcomes,” Dr Coutance said. Despite years of refinement and the use of powerful data models, the results have not dramatically changed. Patients do not necessarily experience longer lifespans, nor do waiting list deaths significantly decrease.

The problem, experts say, lies deeper than algorithms or medical categories. Predictive models, while helpful, are still imperfect. They cannot fully capture the complexity of human illness. Meanwhile, status-based systems may be influenced by varying hospital practices, which can lead to inconsistencies in patient care and outcomes across different healthcare settings. Each method tries to balance three difficult goals—urgency, fairness and long-term success—but none has managed to do so flawlessly, leading to ongoing debates about the effectiveness of these approaches in addressing the complexities of human illness.

As medical technology evolves, new challenges continue to emerge. The growing use of mechanical support devices, shifting patient profiles, and better data analytics are constantly reshaping how decisions are made, leading to a need for more flexible and responsive decision-making frameworks that can accommodate these changes. Systems must adapt, but adaptation alone is not enough.

In the end, the most uncomfortable truth remains unchanged. The real crisis is not how hearts are distributed, but how few are available in the first place. The debate over allocation, while important, risks overshadowing this basic reality.

For patients and their families, the issue is painfully simple. Behind every statistic is a person waiting, hoping, and often running out of time. Until the global shortage of donor organs is addressed, even the most advanced system will struggle to deliver what everyone is searching for—a fair chance at life.